RESUMEN
OBJECTIVE: to evaluate the factors associated with non-closure of protective ileostomy after anterior resection of the rectum with total mesorectum excision for rectal cancer, the morbidity associated with the closure of ileostomies and the rate of permanent ileostomy in patients with rectal adenocarcinoma. METHODS: we conducted a retrospective study with 174 consecutive patients diagnosed with rectal tumors, of whom 92 underwent anterior resection of the rectum with coloanal or colorectal anastomosis and protective ileostomy, with curative intent. We carried out a multivariate analysis to determine the factors associated with definite permanence of the stoma, as well as studied the morbidity of patients who underwent bowel continuity restoration. RESULTS: In the 84-month follow-up period, 54 of the 92 patients evaluated (58.7%) had the ileostomy closed and 38 (41.3%) remained with the stoma. Among the 62 patients who had the ileostomy closed, 11 (17.7%) presented some type of postoperative complication: three had ileal anastomosis dehiscence, five had intestinal obstruction, two had surgical wound infection, and one, pneumonia. Eight of these patients required a new stoma. CONCLUSION: according to the multivariate analysis, the factors associated with stoma permanence were anastomotic fistula, presence of metastases and closure of the ileostomy during chemotherapy.
OBJETIVO: avaliar os fatores associados ao não fechamento de ileostomia protetora após ressecção anterior do reto com excisão total do mesorreto por câncer retal, a morbidade associada ao fechamento destas ileostomias e a taxa de estomia permanente em pacientes com adenocarcinoma retal. MÉTODOS: estudo retrospectivo de 174 pacientes consecutivos com diagnóstico de tumores retais, dos quais 92 foram submetidos à ressecção anterior do reto com intenção curativa, anastomose coloanal ou colorretal e ileostomia de proteção. Foi realizada análise multivariada visando a determinar os fatores associados à permanência definitiva da estomia, assim como o estudo da morbidade nos que se submeteram à reconstrução do trânsito. RESULTADOS: no período de seguimento de 84 meses, 54 dos 92 pacientes avaliados (58,7%) tiveram a ileostomia fechada e 38 (41,3%) permaneceram com a estomia. Entre os 62 pacientes que tiveram a ileostomia fechada, 11 (17,7%) apresentaram algum tipo de complicação pós-operatória: três com deiscência de anastomose ileal, cinco com obstrução intestinal, dois com infecção de ferida operatória e um com pneumonia. Oito destes pacientes necessitaram de um novo estoma. CONCLUSÃO: de acordo com a análise multivariada, os fatores associados à permanência da estomia foram fístula de anastomose, presença de metástases e fechamento da ileostomia durante quimioterapia.
Asunto(s)
Adenocarcinoma/cirugía , Tránsito Gastrointestinal , Ileostomía/métodos , Proctectomía/métodos , Neoplasias del Recto/cirugía , Adenocarcinoma/tratamiento farmacológico , Adenocarcinoma/rehabilitación , Adulto , Anciano , Anastomosis Quirúrgica/métodos , Femenino , Humanos , Ileostomía/efectos adversos , Ileostomía/rehabilitación , Masculino , Persona de Mediana Edad , Análisis Multivariante , Complicaciones Posoperatorias , Proctectomía/efectos adversos , Proctectomía/rehabilitación , Fístula Rectal/complicaciones , Neoplasias del Recto/tratamiento farmacológico , Neoplasias del Recto/rehabilitación , Estudios Retrospectivos , Factores de Riesgo , Estomas Quirúrgicos/efectos adversos , Factores de Tiempo , Resultado del TratamientoRESUMEN
AIM: Enhanced recovery after surgery programs aims to standardize care, improving colorectal surgery outcomes. Older patients are a challenge population for these programs. The aim of this manuscript is to explore the effect of application Enhanced recovery after surgery protocol among older patients and high-risk patients undergone colorectal surgery for cancer. METHOD: Since January 2005, until September 2016, 1189 consecutive patients underwent elective Colorectal Surgery and treated according to our Enhanced recovery after surgery protocol. Patients are divided in three groups according to age: Group1 under 69 y-o (control group), Group2 70 to 79 y-o and Group3 over 80 y-o. Primary end point was Time to Readiness to Discharge. RESULTS: Median Time to Readiness to Discharge was 4 days (3-30) in Group 1, 5 (3-47) in Group 2 and 5 (3-19) in Group 3. Length of stay in Group 1 had a median length of 6 days (3-58), in Group 2 of 8 days (3-70) and in Group 3 of 8 days (3-53). CONCLUSIONS: Once more Enhanced recovery after surgery program has showed its efficacy in colorectal surgery field. Moreover, our experience has underlined the need to concentrate efforts mainly on older and high-risk patients.
Asunto(s)
Adenocarcinoma/cirugía , Neoplasias Colorrectales/cirugía , Convalecencia , Adenocarcinoma/rehabilitación , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Neoplasias Colorrectales/rehabilitación , Procedimientos Quirúrgicos del Sistema Digestivo , Femenino , Humanos , Laparoscopía , Tiempo de Internación/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Cooperación del Paciente , Readmisión del Paciente/estadística & datos numéricos , Evaluación de Programas y Proyectos de Salud , Estudios Retrospectivos , RiesgoRESUMEN
RESUMO Objetivo: avaliar os fatores associados ao não fechamento de ileostomia protetora após ressecção anterior do reto com excisão total do mesorreto por câncer retal, a morbidade associada ao fechamento destas ileostomias e a taxa de estomia permanente em pacientes com adenocarcinoma retal. Métodos: estudo retrospectivo de 174 pacientes consecutivos com diagnóstico de tumores retais, dos quais 92 foram submetidos à ressecção anterior do reto com intenção curativa, anastomose coloanal ou colorretal e ileostomia de proteção. Foi realizada análise multivariada visando a determinar os fatores associados à permanência definitiva da estomia, assim como o estudo da morbidade nos que se submeteram à reconstrução do trânsito. Resultados: no período de seguimento de 84 meses, 54 dos 92 pacientes avaliados (58,7%) tiveram a ileostomia fechada e 38 (41,3%) permaneceram com a estomia. Entre os 62 pacientes que tiveram a ileostomia fechada, 11 (17,7%) apresentaram algum tipo de complicação pós-operatória: três com deiscência de anastomose ileal, cinco com obstrução intestinal, dois com infecção de ferida operatória e um com pneumonia. Oito destes pacientes necessitaram de um novo estoma. Conclusão: de acordo com a análise multivariada, os fatores associados à permanência da estomia foram fístula de anastomose, presença de metástases e fechamento da ileostomia durante quimioterapia.
ABSTRACT Objective: to evaluate the factors associated with non-closure of protective ileostomy after anterior resection of the rectum with total mesorectum excision for rectal cancer, the morbidity associated with the closure of ileostomies and the rate of permanent ileostomy in patients with rectal adenocarcinoma. Methods: we conducted a retrospective study with 174 consecutive patients diagnosed with rectal tumors, of whom 92 underwent anterior resection of the rectum with coloanal or colorectal anastomosis and protective ileostomy, with curative intent. We carried out a multivariate analysis to determine the factors associated with definite permanence of the stoma, as well as studied the morbidity of patients who underwent bowel continuity restoration. Results: In the 84-month follow-up period, 54 of the 92 patients evaluated (58.7%) had the ileostomy closed and 38 (41.3%) remained with the stoma. Among the 62 patients who had the ileostomy closed, 11 (17.7%) presented some type of postoperative complication: three had ileal anastomosis dehiscence, five had intestinal obstruction, two had surgical wound infection, and one, pneumonia. Eight of these patients required a new stoma. Conclusion: according to the multivariate analysis, the factors associated with stoma permanence were anastomotic fistula, presence of metastases and closure of the ileostomy during chemotherapy.
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Anciano , Neoplasias del Recto/cirugía , Tránsito Gastrointestinal , Ileostomía/métodos , Adenocarcinoma/cirugía , Proctectomía/métodos , Complicaciones Posoperatorias , Neoplasias del Recto/tratamiento farmacológico , Neoplasias del Recto/rehabilitación , Factores de Tiempo , Anastomosis Quirúrgica/métodos , Ileostomía/efectos adversos , Ileostomía/rehabilitación , Adenocarcinoma/tratamiento farmacológico , Adenocarcinoma/rehabilitación , Análisis Multivariante , Estudios Retrospectivos , Factores de Riesgo , Fístula Rectal/complicaciones , Resultado del Tratamiento , Estomas Quirúrgicos/efectos adversos , Proctectomía/efectos adversos , Proctectomía/rehabilitación , Persona de Mediana EdadRESUMEN
BACKGROUND: Although men presenting with clinically localized prostate cancer (PrCA) often are treated with radical prostatectomy or radiation therapy with curative intent, about 25-40% develop biochemically recurrent PrCA within 5 years of treatment, which has no known cure. Studies suggest that carotenoid and tocopherol intake may be associated with PrCA risk and progression. We examined plasma carotenoid and tocopherol levels in relation to prostate-specific antigen (PSA) levels among men with PSA-defined biochemical recurrence of PrCA. METHODS: Data analyzed were from a 6-month diet, physical activity and stress-reduction intervention trial conducted in South Carolina among biochemically recurrent PrCA patients (n=39). Plasma carotenoids and tocopherol levels were measured using high-performance liquid chromatography (HPLC). Linear regression was used to estimate least-square means comparing PSA levels of men with high versus low carotenoid/tocopherol levels, adjusting for covariates. RESULTS: After adjusting for baseline PSA level, plasma cis-lutein/zeaxanthin level at 3 months was related inversely to PSA level at 3 months (P=0.0008), while α-tocopherol (P=0.01), ß-cryptoxanthin (P=0.01), and all-trans-lycopene (P=0.004) levels at 3 months were related inversely to PSA levels at 6-months. Percent increase in α-tocopherol and trans-ß-carotene levels from baseline to month 3 were associated with lower PSA levels at 3 and 6 months. Percent increase in ß-cryptoxanthin, cis-lutein/zeaxanthin and all-trans-lycopene were associated with lower PSA levels at 6 months only. CONCLUSIONS: Certain plasma carotenoids and tocopherols were related inversely to PSA levels at various timepoints, suggesting that greater intake of foods containing these micronutrients might be beneficial to men with PSA-defined PrCA recurrence.
Asunto(s)
Adenocarcinoma/sangre , Carotenoides/sangre , Recurrencia Local de Neoplasia/sangre , Antígeno Prostático Específico/sangre , Neoplasias de la Próstata/sangre , Tocoferoles/sangre , Adenocarcinoma/dietoterapia , Adenocarcinoma/rehabilitación , Anciano , Cromatografía Líquida de Alta Presión , Dietoterapia/métodos , Progresión de la Enfermedad , Terapia por Ejercicio/métodos , Humanos , Masculino , Persona de Mediana Edad , Atención Plena/métodos , Neoplasias de la Próstata/dietoterapia , Neoplasias de la Próstata/rehabilitación , Factores de RiesgoRESUMEN
Radical prostatectomy (RP) and radiotherapy (RT) are highly effective in improving prostate cancer survival. However, both have a detrimental effect on erectile function (EF). Penile rehabilitation consists of understanding the mechanisms that cause erectile dysfunction (ED) and utilizing pharmacologic agents, devices or interventions to promote male sexual function. For the past decade, many researchers have pursued to define effective treatment modalities to improve ED after prostate cancer treatment. Despite the understanding of the mechanisms and well-established rationale for postprostate treatment penile rehabilitation, there is still no consensus regarding effective rehabilitation programs. This article reviews a contemporary series of trials that assess penile rehabilitation and explore treatment modalities that might play a role in the future. Published data and trials related to penile rehabilitation after RP and RT were reviewed and presented. Although recent trials have shown that most therapies are well-tolerated and aid in some degree on EF recovery, we currently do not have tangible evidence to recommend an irrefutable penile rehabilitation algorithm. However, advancements in research and technology will ultimately create and refine management options for penile rehabilitation.
Asunto(s)
Adenocarcinoma/rehabilitación , Equipos y Suministros , Disfunción Eréctil/rehabilitación , Inhibidores de Fosfodiesterasa 5/uso terapéutico , Prostatectomía , Neoplasias de la Próstata/rehabilitación , Radioterapia , Vasodilatadores/uso terapéutico , Adenocarcinoma/terapia , Antagonistas Adrenérgicos alfa/uso terapéutico , Alprostadil/uso terapéutico , Humanos , Inyecciones , Masculino , Papaverina/uso terapéutico , Fentolamina/uso terapéutico , Neoplasias de la Próstata/terapia , Supositorios , Terapia por Ultrasonido , Vibración/uso terapéuticoRESUMEN
PURPOSE: The association of a loop ileostomy decreases the severity of complications after rectal surgery but can increase the postoperative stay. The aim of this study is to investigate if a diverting ileostomy influences the postoperative outcomes in a series of patients included in a multimodal rehabilitation program (MMRP). METHODS: We analyzed a series of 104 patients that underwent elective surgery with primary anastomosis for rectal adenocarcinoma using a MMRP: 66 men and 38 women, with a median age of 64 (IQR: 55-75) years. Group A included patients with an associated loop ileostomy, and Group B, those without a protective stoma. RESULTS: Group A = 58, group B = 46 patients without differences in age, ASA, BMI and other risk factors, nor in the surgical approach (laparoscopic in 34%), although there were more neoadjuvant treatments in group A: 77.5 vs. 36.9%; P=.001. In group A, the most common operation was total mesorectal excision (96%) and in the B, a subtotal mesorectal excision (90%). There were no differences in postoperative complications (Group A 34.4 vs. group B28.2%; P=.322), anastomotic leaks (8.3 vs. 10.8%; P=.475), or postoperative ileus (20.7 vs. 10.9%; P=.140), neither in postoperative stay (7.9 vs. 6.9 days; P= .058, readmissions (7 vs. 13.6%; P= .22), or postoperative stay, including readmissions (8.4 vs. 9.1 days; P= .49). CONCLUSIONS: The association of a loop ileostomy does not extend the length of stay nor increases the rate of complications in patients that underwent a rectal resection with anastomosis included in a MMRP.
Asunto(s)
Adenocarcinoma/rehabilitación , Adenocarcinoma/cirugía , Ileostomía , Neoplasias del Recto/rehabilitación , Neoplasias del Recto/cirugía , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios RetrospectivosRESUMEN
AIMS AND OBJECTIVES: To examine the effects of an early postoperative walking exercise programme on postlobectomy lung cancer patients. BACKGROUND: Few interventional studies on the postoperative health status of lung cancer patients have considered the efficacy of programmes designed to improve critical health variables. DESIGN: A two-group quasi-experimental, longitudinal approach repeated four times examined participant data collected 12-18 hours prior to surgery and again at one, three and six months after surgery. METHODS: We assigned the first 33 enrolled participants to the intervention group and the second 33 to the control group. The intervention was a daily supervised walking exercise programme consisting of 12 weeks of brisk walking exercise that began on the day following transfer to the regular ward along with weekly telephone calls until 12 weeks after discharge. Health status was measured using a structured questionnaire (World Health Organization Quality of Life, brief version) and clinical tests (pulmonary function test and 6-minute walk test). We analysed data using general estimating equations, with p < 0·05 considered significant. RESULTS: Intervention group pulmonary and physical functions were increasingly better over time than those of the control group, with no significant difference in quality of life between the two groups. Compared to the control group, the intervention group earned significantly better values for FVC% at postoperative month 3 and for FEV1 % at postoperative months 3 and 6. Intervention group 6MWT scores were significantly better than those of the control group at postoperative months 1, 3 and 6. CONCLUSION: This study demonstrated the benefits of an early postoperative walking exercise intervention for pulmonary and physical function in postlobectomy lung cancer patients. RELEVANCE TO CLINICAL PRACTICE: The results may guide the design of appropriate interventions in the future. Clinical trials in other populations are needed to confirm the results of this study.
Asunto(s)
Adenocarcinoma/rehabilitación , Terapia por Ejercicio/métodos , Neoplasias Pulmonares/rehabilitación , Adenocarcinoma/enfermería , Adenocarcinoma/cirugía , Ambulación Precoz , Femenino , Humanos , Estudios Longitudinales , Neoplasias Pulmonares/enfermería , Neoplasias Pulmonares/cirugía , Masculino , Persona de Mediana Edad , Periodo Posoperatorio , Calidad de Vida , Pruebas de Función Respiratoria , Encuestas y Cuestionarios , Resultado del TratamientoRESUMEN
INTRODUCTION: Given the poor prognosis for patients diagnosed with pancreatic cancer, therapies that enhance the ability to tolerate adjuvant treatments, reduce the loss of physical functioning and optimize quality of life are critically important. Exercise may represent such a therapy; however, no previous research has investigated the potential impact of exercise on outcomes in pancreatic cancer patients. PURPOSE: This study aimed to determine the safety and efficacy of a 6-month supervised exercise program in a pancreatic cancer patient undergoing adjuvant treatment. METHODS: A case study was performed on a 49-yr-old male diagnosed with stage IIb pancreatic cancer. The patient had surgery (Whipple resection) followed by adjuvant chemotherapy (gemcitabine and fluorouracil) and radiotherapy (45 Gy). The patient initiated a supervised exercise program involving twice weekly resistance and aerobic exercise sessions during adjuvant therapy. Outcomes were assessed at baseline and after 3 and 6 months of exercise. RESULTS: The exercise program was well tolerated with 73% attendance throughout the 6 months. No treatment toxicities prevented the patient from complying with adjuvant treatment plans. Considerable improvements were observed at both 3- and 6-month assessment points for all measures of physical capacity and functional ability, lean mass, physical activity levels, general health and disease-specific quality of life, cancer-related fatigue, sleep quality, and psychological distress. CONCLUSIONS: In this first reported clinical case, exercise led to improvements in a variety of patient outcomes during adjuvant therapy for pancreatic cancer. This initial evidence has important clinical implications, indicating that exercise may be an effective adjunct therapy for the management of pancreatic cancer. Future trials are needed to confirm and expand our initial findings.
Asunto(s)
Adenocarcinoma/rehabilitación , Terapia por Ejercicio , Neoplasias Pancreáticas/rehabilitación , Adenocarcinoma/terapia , Composición Corporal , Densidad Ósea , Quimioterapia Adyuvante , Prueba de Esfuerzo , Fatiga/prevención & control , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Pancreáticas/terapia , Calidad de Vida , Radioterapia Adyuvante , Trastornos del Sueño-Vigilia/prevención & control , Estrés Psicológico/prevención & controlRESUMEN
El adenocarcinoma nasofaríngeo primario (NAC, por sus siglas en inglés: Nasopharyngeal Adenocarcinoma) es una neoplasia muy rara. Se cree que se origina en las glándulas salivales menores, y representa aproximadamente el 0,5% de todos los cánceres de la nasofaringe. Tiene una serie de características clínicas, que incluyen un inicio insidioso con síntomas progresivos, como la obstrucción nasal y epistaxis, que se extienden por un período de semanas a varios meses. La mayoría de estos tumores se observan en pacientes de edad media (entre los 30-50 años). Se presenta el caso de una paciente de diez años de edad, con obstrucción nasal progresiva y rinitis, a quien se le diagnosticó un adenocarcinoma nasofaríngeo. Lamentablemente, no hay estrategias terapéuticas establecidas; sin embargo, la resección quirúrgica es el tratamiento de elección, con radioterapia concomitante o sin ella. Estas estrategias son similares a las recomendadas para el carcinoma escamocelular nasofaríngeo, pues casi todos los pacientes se benefician del tratamiento quirúrgico; no obstante, el papel de la quimioterapia y la radioterapia aún no es claro. Un sistema de clasificación correcta y la gestión de un tratamiento más específico para el manejo del adenocarcinoma nasofaríngeo deben establecerse...
Primary Nasopharyngeal Adenocarcinoma (NAC) is an extremely rare neoplasm believed to originate from minor salivary glands which accounts for approximately 0.5% of all nasopharyngeal cancer. It has a series of clinical characteristics including an insidious onset with slow progressive symptoms, such as nasal obstruction and epistaxis that spans a period of weeks to several months. Most of these tumors are seen in middle aged patients (30-50 years of age). We report a case of a 10 year old female patient presenting with progressive nasal obstruction and rhinitis who was diagnosed with a NAC. Unfortunately no treatment strategies are established; however surgical management is the treatment of choice, with or without concomitant radiotherapy. These strategies are similar to the ones recommended for nasopharyngeal squamous carcinoma. Almost all patients benefit from surgery, nevertheless the role of chemotherapy and radiotherapy is not clear. An accurate staging system and most select management for NAC needed to be established...
Asunto(s)
Niño , Adenocarcinoma Papilar , Adenocarcinoma/etiología , Adenocarcinoma/rehabilitación , Cirugía General , Nasofaringe , Neoplasias NasofaríngeasRESUMEN
The present study reports on the surgical and prosthodontic rehabilitation of 46 patients, 31 male and 15 female, after resection of oral tumors. The treatment was carried out from 2004 to 2007 at the Department of Prosthodontics, University of Bern, with a follow-up time of 3 to 6 years. The average age at diagnosis was 54 years. 76% of all tumors were squamous cell carcinoma, followed by adenocarcinoma. Resection of the tumors including soft and/or hard tissues was performed in all patients. 80% of them additionally underwent radiotherapy and 40% chemotherapy. A full block resection of the mandible was perfomed in 23 patients, and in 10 patients, the tumor resection resulted in an oronasal communication. 29 patients underwent grafting procedures, mostly consisting of a free fibula flap transplant. To enhance the prosthetic treatment outcome and improve the prosthesis stability, a total of 114 implants were placed. However, 14 implants were not loaded because they failed during the healing period or the patient could not complete the final treatment with the prostheses. The survival rate of the implants reached 84.2% after 4 to 5 years. Many patients were only partially dentate before the tumors were detected, and further teeth had to be extracted in the course of the tumor therapy. Altogether, 31 jaws became or remained edentulous. Implants provide stability and may facilitate the adaptation to the denture, but their survival rate was compromised. Mostly, patients were fitted with removable prostheses with obturators in the maxilla and implant-supported complete dentures with bars in the mandible. Although sequelae of tumor resection are similar in many patients, the individual intermaxillary relations, facial morphology and functional capacity vary significantly. Thus, individual management is required for prosthetic rehabilitation.
Asunto(s)
Carcinoma de Células Escamosas/rehabilitación , Prótesis Dental de Soporte Implantado , Neoplasias Maxilomandibulares/rehabilitación , Arcada Edéntula/rehabilitación , Neoplasias de la Boca/rehabilitación , Adenocarcinoma/rehabilitación , Adenocarcinoma/cirugía , Adenocarcinoma/terapia , Trasplante Óseo , Carcinoma de Células Escamosas/cirugía , Carcinoma de Células Escamosas/terapia , Quimioterapia Adyuvante , Implantación Dental Endoósea , Dentadura Completa , Femenino , Colgajos Tisulares Libres , Humanos , Neoplasias Maxilomandibulares/cirugía , Neoplasias Maxilomandibulares/terapia , Masculino , Persona de Mediana Edad , Neoplasias de la Boca/cirugía , Neoplasias de la Boca/terapia , Obturadores Palatinos , Radioterapia Adyuvante , Resultado del TratamientoRESUMEN
BACKGROUND: After oral tumor resection, structural and functional rehabilitation by means of dental prostheses is complex, and positive treatment outcome is not always predictable. PURPOSE: The objective of the study was to report on oral rehabilitation and quality of life 2-5 years after resection of malignant oral tumors. MATERIALS AND METHODS: Data of 46 patients (57 ± 7 years) who underwent oral tumor surgery were available. More than 50% of tumors were classified T3 or T4. Open oro-nasal defects resulted in 12 patients and full mandibulary block resections in 23 patients. Comprehensive planning, implant placement, and prosthetic rehabilitation followed an interdisciplinary protocol. Analysis comprised tumor location, type of prostheses, implant survival, and quality of life. RESULTS: Because of advanced tumor status, resections resulted in marked alteration of the oral anatomy requiring complex treatment procedures. Prosthetic rehabilitation comprised fixed and removable prostheses, with 104 implants placed in 28 patients (60%). Early implant loss was high (13%) and cumulative survival rate of loaded implants was <90% after 5 years. Prosthetic plans had to be modified because of side effects of tumor therapy, complications with implants and tumor recurrence. The majority of patients rated quality of life favorable, but some experienced impaired swallowing, dry mouth, limited mouth opening, appearance, and soreness. CONCLUSIONS: Some local effects of tumor therapy could not be significantly improved by prosthetic rehabilitation leading to functional and emotional disability. Many patients had passed away or felt too ill to fill the questionnaires. This case series confirms the complex anatomic alterations after tumor resection and the need for individual treatment approaches especially regarding prosthesis design. In spite of disease-related local and general restrictions, most patients gave a positive assessment of quality of life.
Asunto(s)
Carcinoma de Células Escamosas/rehabilitación , Implantes Dentales , Prótesis Dental de Soporte Implantado , Neoplasias de la Boca/rehabilitación , Calidad de Vida , Adaptación Fisiológica , Adenocarcinoma/rehabilitación , Adenocarcinoma/cirugía , Anciano , Carcinoma de Células Escamosas/cirugía , Tejido Conectivo/fisiología , Implantes Dentales/psicología , Fracaso de la Restauración Dental , Femenino , Estudios de Seguimiento , Humanos , Tablas de Vida , Masculino , Persona de Mediana Edad , Neoplasias de la Boca/cirugía , Recuperación de la Función , Encuestas y CuestionariosRESUMEN
OBJECTIVES: Impaired cardiopulmonary reserve is the main cause of inoperability in non-small-cell lung cancer (NSCLC). This study aims to evaluate the role of a preoperative pulmonary rehabilitation (PPR) programme in the improvement of functional parameters, which can enable an increase in the number of patients eligible for surgery. METHODS: From January 2008 to June 2011, we observed a uniform group of 27 patients with NSCLC and chronic obstructive pulmonary disease (COPD). It showed: (i) a body mass index of 21.5 ± 2 kg/m2;; (ii) forced expiratory volume in 1 s (FEV(1)) of 1.14 ± 0.7 l; (iii) maximal peak of oxygen consumption (VO(2)max) of 12.9 ± 1.8 ml/kg/min; (iv) carbon monoxide diffusing capacity (DLCO) of 72 ± 3% predicted; (v) stage IB of lung cancer. All patients underwent a 4-week PPR programme, 6 days a week and were re-evaluated before inclusion for surgery. RESULTS: The rehabilitation programme was completed by all patients and extended by 2 weeks in nine patients, in order to obtain a further functional improvement. A statistically significant increase has been in the values of PaO(2) (60 ± 10 vs 82 ± 12 mmHg), of VO(2)max (12.9 ± 1.8 vs 19.2 ± 2.1 ml/kg/min, P = 0.00001) and of FEV(1) (1.14 ± 0.7 vs 1.65 ± 0.8 l, P = 0.02). All patients underwent a lobectomy, with a postoperative morbidity of 15%. CONCLUSIONS: A 4 to 6-week PPR programme prepares the NSCLC and COPD patients properly for the surgical approach, reducing the functional limitations of inoperability.
Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/rehabilitación , Neoplasias Pulmonares/rehabilitación , Cuidados Preoperatorios/métodos , Enfermedad Pulmonar Obstructiva Crónica/rehabilitación , Adenocarcinoma/rehabilitación , Adenocarcinoma/cirugía , Análisis de los Gases de la Sangre , Ejercicios Respiratorios , Carcinoma de Pulmón de Células no Pequeñas/cirugía , Carcinoma de Células Escamosas/rehabilitación , Carcinoma de Células Escamosas/cirugía , Terapia por Ejercicio/métodos , Femenino , Volumen Espiratorio Forzado/fisiología , Hospitalización , Humanos , Neoplasias Pulmonares/cirugía , Masculino , Persona de Mediana Edad , Enfermedad Pulmonar Obstructiva Crónica/cirugía , Capacidad Vital/fisiologíaRESUMEN
PURPOSE: Peak oxygen consumption (VO(2peak)) is an important predictive factor for long-term prognosis in patients with non-small cell lung cancer (NSCLC). The purpose of this study was to investigate whether 8 weeks of exercise training improves exercise capacity, as assessed by VO(2peak), and other related factors in patients with NSCLC receiving targeted therapy. METHODS: A total of 24 participants with adenocarcinoma were randomly assigned to either the control group (n = 11) or the exercise group (n = 13). Subjects in the exercise group participated in individualized, high-intensity aerobic interval training of exercise. The outcome measures assessed at baseline and after 8 weeks were as follows: VO(2peak) and the percentage of predicted VO(2peak) (%predVO(2peak)), muscle strength and endurance of the right quadriceps, muscle oxygenation during exercise, insulin resistance as calculated by the homeostasis model, high-sensitivity C-reactive protein, and quality of life (QoL) questionnaire inventory. RESULTS: No exercise-related adverse events were reported. After exercise training, VO(2peak) and %predVO(2peak) increased by 1.6 mL kg(-1) min(-1) and 5.3% (p < 0.005), respectively; these changes were associated with improvements in circulatory, respiratory, and muscular functions at peak exercise (all p = 0.001). The exercise group also had less dyspnea (p = 0.01) and favorably lower fatigue (p = 0.05) than baseline. CONCLUSIONS: Patients with NSCLC receiving targeted therapy have quite a low exercise capacity, even with a relatively high QoL. Exercise training appears to improve exercise capacity and alleviate some cancer-related symptoms.
Asunto(s)
Adenocarcinoma/rehabilitación , Terapia por Ejercicio/métodos , Tolerancia al Ejercicio , Neoplasias Pulmonares/rehabilitación , Consumo de Oxígeno , Adenocarcinoma/complicaciones , Adulto , Anciano , Proteína C-Reactiva , Disnea/etiología , Disnea/rehabilitación , Prueba de Esfuerzo , Fatiga/etiología , Fatiga/rehabilitación , Femenino , Humanos , Resistencia a la Insulina , Neoplasias Pulmonares/complicaciones , Masculino , Persona de Mediana Edad , Fuerza Muscular , Resistencia Física , Pronóstico , Músculo Cuádriceps , Calidad de Vida , Encuestas y Cuestionarios , Resultado del TratamientoAsunto(s)
Implantación Dental Endoósea/métodos , Maxilar/cirugía , Procedimientos Quirúrgicos Orales/métodos , Procedimientos de Cirugía Plástica/métodos , Cigoma/cirugía , Adenocarcinoma/rehabilitación , Adenocarcinoma/cirugía , Anciano , Pérdida de Hueso Alveolar/cirugía , Diseño de Prótesis Dental , Prótesis Dental de Soporte Implantado , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Palatinas/rehabilitación , Neoplasias Palatinas/cirugía , Obturadores PalatinosRESUMEN
BACKGROUND: Whether laparoscopic colorectal resection improved recovery within an enhanced recovery program was investigated. METHODS: This study was designed as a query of a prospectively maintained colorectal database to identify 350 patients who underwent elective colorectal resection with primary anastomosis for colorectal cancer between January 1, 2005 and December 31, 2009. Patients were categorized into two groups (laparoscopic and open resection), and demographic, treatment, and outcome variables were independently reviewed for accuracy. A detailed fast-track protocol was prepared and distributed to all patients, department doctors, and nurses to standardize the treatment. RESULTS: A total of 209 patients underwent laparoscopic-assisted colorectal resection, and 141 had open surgery. There was no difference between the two groups in terms of age, sex, BMI, ASA, comorbidity, previous abdominal surgery, preoperative chemoradiotherapy, cancer site, and AJCC 2002 staging. Twenty-three patients in the laparoscopic group required conversion to an open procedure due to hemorrhage, tumor extension, or technical difficulties. Laparoscopic patients had earlier tolerance of diet, bowel movement, flatus and stool canalization, mobilization, suction drain removal, and interruption of analgesic drug administration. Length of postoperative stay was shorter (4 vs. 7 days, p = 0.0004) and fewer postoperative nonsurgical complications (3 vs. 13% p = 0.009) were registered for the laparoscopic group. CONCLUSIONS: This study suggests that within an enhanced recovery program, laparoscopic resection may provide the best short-term clinical outcomes for patients with resectable colorectal cancer.
Asunto(s)
Adenocarcinoma/cirugía , Neoplasias Colorrectales/cirugía , Procedimientos Quirúrgicos Electivos/rehabilitación , Laparoscopía/rehabilitación , Cuidados Posoperatorios/métodos , Cuidados Preoperatorios/métodos , Adenocarcinoma/rehabilitación , Adulto , Anciano , Anciano de 80 o más Años , Colectomía/métodos , Colectomía/rehabilitación , Colectomía/estadística & datos numéricos , Neoplasias Colorrectales/rehabilitación , Bases de Datos Factuales/estadística & datos numéricos , Procedimientos Quirúrgicos Electivos/estadística & datos numéricos , Femenino , Humanos , Ileostomía/métodos , Ileostomía/rehabilitación , Ileostomía/estadística & datos numéricos , Complicaciones Intraoperatorias/epidemiología , Complicaciones Intraoperatorias/prevención & control , Laparoscopía/métodos , Laparoscopía/estadística & datos numéricos , Laparotomía/métodos , Laparotomía/rehabilitación , Laparotomía/estadística & datos numéricos , Tiempo de Internación/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Terapia Neoadyuvante , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/prevención & control , Evaluación de Programas y Proyectos de Salud , Recuperación de la Función , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
BACKGROUND: Despite evidence that physical activity improves the health and well-being of prostate cancer survivors, many men do not engage in sufficient levels of activity. The primary aim of this study (ENGAGE) is to determine the efficacy of a referral and physical activity program among survivors of prostate cancer, in terms of increasing participation in physical activity. Secondary aims are to determine the effects of the physical activity program on psychological well-being, quality of life and objective physical functioning. The influence of individual and environmental mediators on participation in physical activity will also be determined. METHODS/DESIGN: This study is a cluster randomised controlled trial. Clinicians of prostate cancer survivors will be randomised into either the intervention or control condition. Clinicians in the intervention condition will refer eligible patients (n=110) to participate in an exercise program, comprising 12 weeks of supervised exercise sessions and unsupervised physical activity. Clinicians allocated to the control condition will provide usual care to eligible patients (n=110), which does not involve the recommendation of the physical activity program. Participants will be assessed at baseline, 12 weeks, 6 months, and 12 months on physical activity, quality of life, anxiety, depression, self-efficacy, outcome expectations, goals, and socio-structural factors. DISCUSSION: The findings of this study have implications for clinicians and patients with different cancer types or other chronic health conditions. It will contribute to our understanding on the potential impact of clinicians promoting physical activity to patients and the long term health benefits of participating in physical activity programs. TRIAL REGISTRATION: Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12610000609055Deakin University Human Research Ethics Approval 2011-085.
Asunto(s)
Adenocarcinoma/rehabilitación , Terapia por Ejercicio , Neoplasias de la Próstata/rehabilitación , Adenocarcinoma/psicología , Ansiedad/epidemiología , Ansiedad/etiología , Ansiedad/prevención & control , Australia , Depresión/epidemiología , Depresión/etiología , Depresión/prevención & control , Estudios de Seguimiento , Objetivos , Humanos , Masculino , Nueva Zelanda , Selección de Paciente , Neoplasias de la Próstata/psicología , Calidad de Vida , Derivación y Consulta , Autoeficacia , Índice de Severidad de la Enfermedad , Encuestas y Cuestionarios , Sobrevivientes/psicología , Resultado del TratamientoRESUMEN
We investigated the cell-death mechanisms induced in esophageal cancer cells in response to the chemotherapeutic drugs, 5-fluorouracil (5-FU) and cisplatin. Chemosensitive cell lines exhibited apoptosis whereas chemoresistant populations exhibited autophagy and a morphology resembling type II programmed cell death (PCD). Cell populations that respond with autophagy are more resistant and will recover following withdrawal of the chemotherapeutic agents. Specific inhibition of early autophagy induction with siRNA targeted to Beclin 1 and ATG7 significantly enhanced the effect of 5-FU and reduced the recovery of drug-treated cells. Pharmacological inhibitors of autophagy were evaluated for their ability to improve chemotherapeutic effect. The PtdIns 3-kinase inhibitor 3-methyladenine did not enhance the cytotoxicity of 5-FU. Disruption of lysosomal activity with bafilomycin A 1 or chloroquine caused extensive vesicular accumulation but did not improve chemotherapeutic effect. These observations suggest that an autophagic response to chemotherapy is a survival mechanism that promotes chemoresistance and recovery and that selective inhibition of autophagy regulators has the potential to improve chemotherapeutic regimes. Currently available indirect inhibitors of autophagy are, however, ineffective at modulating chemosensitivity in these esophageal cancer cell lines.
Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Autofagia/fisiología , Carcinoma de Células Escamosas/tratamiento farmacológico , Resistencia a Antineoplásicos , Neoplasias Esofágicas/tratamiento farmacológico , Adenocarcinoma/tratamiento farmacológico , Adenocarcinoma/genética , Adenocarcinoma/patología , Adenocarcinoma/rehabilitación , Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Autofagia/efectos de los fármacos , Autofagia/genética , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/patología , Carcinoma de Células Escamosas/rehabilitación , Caspasa 3/metabolismo , Supervivencia Celular/genética , Cisplatino/farmacología , Evaluación Preclínica de Medicamentos , Resistencia a Antineoplásicos/genética , Neoplasias Esofágicas/genética , Neoplasias Esofágicas/patología , Neoplasias Esofágicas/rehabilitación , Fluorouracilo/farmacología , Regulación Neoplásica de la Expresión Génica/fisiología , Humanos , Recuperación de la Función/genética , Células Tumorales Cultivadas , Regulación hacia Arriba/genética , Regulación hacia Arriba/fisiologíaRESUMEN
PURPOSE: Temporalis muscle flap (TMF) provides a reliable solution in reconstruction of extensive intraoral ablative defects, providing a valuable alternative to more complex and extensive reconstructive procedures, combining excellent functional and aesthetic rehabilitation with minimal complications. In this article is described in detail the TMF surgical technique with attention to specific methods useful for preventing facial nerve injury and donor-site deformity. MATERIALS AND METHODS: It is presented the case of a patient with malignant tumour in the region of the upper jaw, palate and inferior half of the nasal cavity, who underwent extensive surgical excision and the resultant defect was successfully reconstructed with TMF. RESULTS: The reconstructive procedure resulted in excellent immediate and long-term functional (aspiration, feeding and speech) and aesthetic results. During the 5-year follow-up period no complications associated with the flap or the temporal implant, used for donor-site reconstruction were encountered and no local recurrence or tumour metastasis was observed. CONCLUSION: The TMF is a reliable, technically easy and anatomically sound technique, which combines excellent aesthetic and functional results with minimal complications, if performed correctly.
Asunto(s)
Adenocarcinoma/cirugía , Neoplasias Maxilares/cirugía , Procedimientos de Cirugía Plástica/métodos , Colgajos Quirúrgicos , Músculo Temporal/cirugía , Adenocarcinoma/patología , Adenocarcinoma/rehabilitación , Dentadura Completa Superior , Humanos , Masculino , Neoplasias Maxilares/rehabilitación , Persona de Mediana Edad , Neoplasias Nasales/rehabilitación , Neoplasias Nasales/cirugía , Neoplasias Palatinas/rehabilitación , Neoplasias Palatinas/cirugía , Colgajos Quirúrgicos/irrigación sanguínea , Arterias Temporales/cirugíaRESUMEN
The incidence of oesophageal adenocarcinoma has risen throughout the Western world over the last three decades. The prognosis remains poor as many patients are elderly and present with advanced disease. Those patients who are suitable for resection remain at high risk of disease recurrence. It is important that cancer patients take part in a follow up protocol to detect disease recurrence, offer psychological support, manage nutritional disorders and facilitate audit of surgical outcomes. Despite the recognition that regular postoperative follow up plays a key role in ongoing care of cancer patients, there is little consensus on the nature of the process. This paper reviews the published literature to determine the optimal timing and type of patient follow up for those after curative oesophageal resection.
Asunto(s)
Adenocarcinoma/rehabilitación , Neoplasias Esofágicas/rehabilitación , Esofagectomía/métodos , Recurrencia Local de Neoplasia/prevención & control , Cuidados Posoperatorios/métodos , Adenocarcinoma/cirugía , Neoplasias Esofágicas/cirugía , Estudios de Seguimiento , Humanos , Incidencia , Recurrencia Local de Neoplasia/epidemiologíaRESUMEN
BACKGROUND: Laparoscopy is associated with less pain and organ dysfunction than open surgery. Improved perioperative care (enhanced recovery programmes, fast-track methodology) has also led to reduced morbidity and a shorter hospital stay. The effects of a combination of laparoscopic resection and accelerated recovery have not been examined previously in the context of gastric surgery. METHODS: This was a prospective study of 32 consecutive patients undergoing laparoscopic gastric resection combined with an enhanced recovery protocol (early oral intake, no drains or nasogastric tubes, no epidural analgesia, use of a urinary catheter for less than 24 h and planned discharge 72 h after surgery). Outcomes included length of hospital stay, intraoperative and postoperative complications, readmission rate and 30-day mortality. RESULTS: Operative procedures were elective distal or subtotal gastrectomy (22 patients) and total gastrectomy (10). Median length of hospital stay was 4 (range 2-30) days. There were two major complications: postoperative bleeding requiring reoperation and pulmonary embolism. Two patients required readmission, one for a wound abscess and one for treatment of a urinary tract infection. There were no deaths within 30 days. CONCLUSION: Minimally invasive gastrectomy with enhanced postoperative recovery results in a short hospital stay and low morbidity rate.